Pluri Inc. Cost of Services, Licenses and Services (Deprecated 2018-01-31)
Pluri Inc. (PLUR) reported Cost of Services, Licenses and Services (Deprecated 2018-01-31) of $7.00 million for the 6-month period ending 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Expense Statement
us-gaap:CostOfServicesLicensesAndServices · last filed 2014-02-05
- Pluri Inc. cost of services, licenses and services (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $0.00.
- Pluri Inc. cost of services, licenses and services (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $7.00M.
| Period end | Cost of Services, Licenses and Services (Deprecated 2018-01-31) 3 month | Cost of Services, Licenses and Services (Deprecated 2018-01-31) 6 month |
|---|---|---|
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $7.00M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $7.00M 10-Q · filed 2013-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |